UNICEF’s ACT-A Supplies Financing Facility reporting
Key data on the utilisation of funds contributed to the Access to COVID-19 Tools Accelerator Supplies Financing Facility (ACT-A SFF).
As part of its contribution to the work of the Access to COVID-19 Tools Accelerator (ACT-A), UNICEF launched the ACT-A Supplies Financing Facility (ACT-A SFF). a UNICEF-housed pooled fund specifically designed to secure low- and middle-income countries’ access to key COVID-19 supplies via UNICEF Procurement Services.
ACT-A was a global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A SFF supported the procurement of immunization-related supplies not covered by the COVAX Facility and focused on supply-related expenses such as freight, in-country logistics and insurance.
Financing contributions to the ACT-A SFF could be directed toward three key COVID-19 health supplies: immunization (including syringes and safe injection equipment, PPE, freight and in-country logistics), laboratory and diagnostics, and therapeutics (including antivirals or oxygen therapy supplies).